WallStSmart

Corteva Inc (CTVA)vsICL Israel Chemicals Ltd (ICL)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Corteva Inc generates 131% more annual revenue ($17.81B vs $7.71B). CTVA leads profitability with a 5.7% profit margin vs 4.0%. CTVA appears more attractively valued with a PEG of 1.32. ICL earns a higher WallStSmart Score of 59/100 (C).

CTVA

Buy

52

out of 100

Grade: C-

Growth: 2.0Profit: 6.0Value: 5.0Quality: 6.5
Piotroski: 5/9Altman Z: 1.49

ICL

Buy

59

out of 100

Grade: C

Growth: 6.7Profit: 5.0Value: 4.7Quality: 6.0
Piotroski: 2/9Altman Z: 2.13
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for CTVA.

ICLUndervalued (+0.5%)

Margin of Safety

+0.5%

Fair Value

$5.78

Current Price

$5.36

$0.42 discount

UndervaluedFair: $5.78Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CTVA4 strengths · Avg: 9.0/10
Operating MarginProfitability
30.1%10/10

Strong operational efficiency at 30.1%

Market CapQuality
$55.98B9/10

Large-cap with strong market position

Debt/EquityHealth
0.199/10

Conservative balance sheet, low leverage

Price/BookValuation
2.1x8/10

Reasonable price relative to book value

ICL3 strengths · Avg: 9.3/10
Price/BookValuation
1.1x10/10

Reasonable price relative to book value

EPS GrowthGrowth
51.6%10/10

Earnings expanding 51.6% YoY

Revenue GrowthGrowth
16.5%8/10

16.5% revenue growth

Areas to Watch

CTVA4 concerns · Avg: 2.5/10
Return on EquityProfitability
4.0%3/10

ROE of 4.0% — below average capital efficiency

Profit MarginProfitability
5.7%3/10

5.7% margin — thin

P/E RatioValuation
49.9x2/10

Premium valuation, high expectations priced in

Revenue GrowthGrowth
-1.2%2/10

Revenue declined 1.2%

ICL4 concerns · Avg: 2.8/10
Return on EquityProfitability
4.3%3/10

ROE of 4.3% — below average capital efficiency

Profit MarginProfitability
4.0%3/10

4.0% margin — thin

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

PEG RatioValuation
9.442/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : CTVA

The strongest argument for CTVA centers on Operating Margin, Market Cap, Debt/Equity. PEG of 1.32 suggests the stock is reasonably priced for its growth.

Bull Case : ICL

The strongest argument for ICL centers on Price/Book, EPS Growth, Revenue Growth. Revenue growth of 16.5% demonstrates continued momentum.

Bear Case : CTVA

The primary concerns for CTVA are Return on Equity, Profit Margin, P/E Ratio. A P/E of 49.9x leaves little room for execution misses.

Bear Case : ICL

The primary concerns for ICL are Return on Equity, Profit Margin, Piotroski F-Score. Thin 4.0% margins leave little buffer for downturns.

Key Dynamics to Monitor

CTVA profiles as a value stock while ICL is a growth play — different risk/reward profiles.

ICL carries more volatility with a beta of 1.00 — expect wider price swings.

ICL is growing revenue faster at 16.5% — sustainability is the question.

ICL generates stronger free cash flow (93M), providing more financial flexibility.

Bottom Line

ICL scores higher overall (59/100 vs 52/100) and 16.5% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Corteva Inc

BASIC MATERIALS · AGRICULTURAL INPUTS · USA

Corteva, Inc. (also known as Corteva Agriscience) is a major American agricultural chemical and seed company that was the agricultural unit of DowDuPont prior to being spun off as an independent public company.

Visit Website →

ICL Israel Chemicals Ltd

BASIC MATERIALS · AGRICULTURAL INPUTS · USA

ICL Group Ltd, is a company specialized in minerals and chemical products worldwide. The company is headquartered in Tel Aviv, Israel.

Visit Website →

Want to dig deeper into these stocks?